Literature DB >> 15487980

Overcoming obstacles: collaboration for change.

M M Funnell1.   

Abstract

Effective diabetes care requires a partnership between prepared, proactive practice teams and informed, activated patients. Diabetes education helps to overcome many of the barriers to effective self-management by enabling people with diabetes to make informed decisions about their day-to-day self-care. Both psychosocial and health outcomes have been improved through a variety of training programmes; however, education must be coupled with ongoing self-management support if these benefits are to be sustained. The principal goal of diabetes education has undergone a major shift over the past few years--evolving from primarily didactic interventions, focused on encouraging patients to adhere to the prescribed therapy, towards more interactive learning that supports people in making informed, self-directed decisions.

Entities:  

Mesh:

Year:  2004        PMID: 15487980     DOI: 10.1530/eje.0.151t019

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  4 in total

Review 1.  Diabetes care - insulin delivery in a changing world.

Authors:  Alan Marcus
Journal:  Medscape J Med       Date:  2008-05-20

2.  Health care professionals meeting with individuals with Type 2 diabetes and obesity: Balancing coaching and caution.

Authors:  Irene Svenningsson; Lillemor R-M Hallberg; Birgitta Gedda
Journal:  Int J Qual Stud Health Well-being       Date:  2011-06-29

3.  A study of patients' perceptions of diabetes care delivery and diabetes: propositional analysis in people with type 1 and 2 diabetes managed by group or usual care.

Authors:  Marzia Raballo; Martina Trevisan; Anna Franca Trinetta; Lorena Charrier; Franco Cavallo; Massimo Porta; Marina Trento
Journal:  Diabetes Care       Date:  2011-12-30       Impact factor: 19.112

Review 4.  Partnering with diabetes educators to improve patient outcomes.

Authors:  Sandra D Burke; Dawn Sherr; Ruth D Lipman
Journal:  Diabetes Metab Syndr Obes       Date:  2014-02-12       Impact factor: 3.168

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.